Although the dorsal hippocampus (
dHPC) and serotonin1A (5-HT1A) receptor are involved in cognition, their roles in
cognitive impairments in
Parkinson' disease (PD) are still unclear. In the present study, the effects of the
5-HT1A receptor agonist
8-OH-DPAT and antagonist WAY100635 administrated into the
dHPC of rats were assessed in T-maze rewarded alternation test for working memory and in hole-board test for long-term habituation. Unilateral
6-hydroxydopamine (6-OHDA) lesions of the medial forebrain bundle in rats impaired working memory and long-term habituation, decreased
dopamine (DA) levels in the medial prefrontal cortex (mPFC),
dHPC and ventral hippocampus (vHPC), and decreased the mean density of 5-HT1A receptors and co-localization of
5-HT1A receptor and
excitatory amino acid carrier 1-immunoreactive (EAAC1-ir) neurons in the
dHPC compared to
sham-operated rats. Activation of
dHPC 5-HT1A receptors by local infusion of
8-OH-DPAT impaired working memory and long-term habituation in both
sham-operated and the 6-OHDA-lesioned rats. Furthermore, blockade of
dHPC 5-HT1A receptors by WAY100635 improved the memories in the 6-OHDA-lesioned rats, but had no effects in
sham-operated rats. Additionally,
dHPC injection of
8-OH-DPAT decreased
noradrenaline (NA) levels, increased
5-HT levels in the mPFC,
dHPC and vHPC in
sham-operated and lesioned rats, while WAY100635 increased DA and NA levels only in lesioned rats. The results of the present study suggest that
dHPC 5-HT1A receptors regulate
cognitive impairments in PD by changes of monoamines in the related brain regions.